Ignite Creation Date:
2025-12-25 @ 4:23 AM
Ignite Modification Date:
2026-04-18 @ 7:31 AM
Study NCT ID:
NCT02283320
Status:
COMPLETED
Last Update Posted:
2016-04-18
First Post:
2014-10-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung Cancer
Sponsor:
BIND Therapeutics
Organization: